References in periodicals archive ?
The technology uses a measles virus vaccine backbone, and measles vaccines have already been successfully used in well over a billion individuals over the last 3040 years, which suggests an excellent safety and immunogenicity profile as well as an efficient production process.
The two products, Freeze-dried Live Attenuated Measles, Rubella Combined Vaccine Kitasatodaiichisankyo and Freeze-dried Live Attenuated Measles Virus Vaccine Kitasatodaiichisankyo, are being recalled due to results of stability monitoring revealing a possibility that potency of the measles virus falls below the approved standard within the product shelf-life.
paragraph])([paragraph]) Documented receipt of 2 doses of live measles virus vaccine, laboratory evidence of immunity, documentation of physician-diagnosed measles, or birth before 1957.
Full browser ?